Header Logo

Connection

HESHAM MOHAMED to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications HESHAM MOHAMED has written about Clinical Trials, Phase II as Topic.
HESHAM MOHAMED
Connection Strength
0.033
Clinical Trials, Phase II as Topic
  1. Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2016 06; 16(6):341-349.e1.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.